Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Yamei Hu, Zigang Dong, Kangdong Liu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 61
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
Veronica Vella, Rosamaria Lappano, Eduardo Bonavita, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 4, pp. 693-723
Open Access | Times Cited: 27
Multiple functions of HMGB1 in cancer
Guangyao Lv, Meng‐Lin Yang, Keke Gai, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
Roles of non-coding RNAs and exosomal non-coding RNAs, particularly microRNAs, long non-coding RNAs, and circular RNAs, in pathogenic mechanisms behind chronic pain: A review
Zhongkai Wang, Peng Jiao
International Journal of Biological Macromolecules (2025), pp. 141945-141945
Closed Access
Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway
Danni Xu, Jiangzheng Zeng, Sun Huamao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 7335-7347
Open Access | Times Cited: 20
Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma
Lin Qiu, Anqi Tao, Fei Liu, et al.
BMC Genomic Data (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
José A. Peña-Flores, Mercedes Bermúdez, Rosalío Ramos‐Payán, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Circ_0001589/miR‐1248/HMGB1 axis enhances EMT‐mediated metastasis and cisplatin resistance in cervical cancer
Teng Ma, Jianxin Guo, Jian Han, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 11, pp. 1645-1658
Closed Access | Times Cited: 6
Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy
Yishimei Si, Jǐnjīng Xǔ, Linghan Meng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
MIAT shuttled by tumor‐secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis
Shuyao Zhang, Junyong Zhong, Dainian Guo, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 4
Cardiomyocyte Regeneration in Human Myocarditis
Andrea Frustaci, Eleonora Foglio, Federica Limana, et al.
(2024)
Open Access | Times Cited: 1
The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR)
Giuseppina Liguori, Margherita Cerrone, Annarosaria De Chiara, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10160-10160
Open Access | Times Cited: 10
Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
Jiaxin Xiao, HE Xiu-sheng
Cancer Management and Research (2021) Vol. Volume 13, pp. 8781-8794
Open Access | Times Cited: 10
Emerging roles of HMGB1-related lncRNA: from molecular biology to clinical application
Tianyi Wang, Xueqi Gan
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1149-C1160
Closed Access | Times Cited: 7
Inflammatory Mediators and GBM Malignancy: Current Scenario and Future Prospective
Ilya V. Ulasov, Vaishali Singh, Anastasia Laevskaya, et al.
Discovery Medicine (2023) Vol. 35, Iss. 177, pp. 458-458
Open Access | Times Cited: 3
DUSP1 regulates the JAK2/STAT3 signaling pathway through targeting miR-21 in cervical cancer cells
Hailin Chen, Songsen Ren, Hui Wan, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 8, pp. 40-44
Open Access | Times Cited: 3
Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma
Xuanyu Zhang, Chao Shang, Xue Qiao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115509-115509
Open Access | Times Cited: 3
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
Junjun Ling, Yu Huang, Zhen Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma
Lingyu Yuan, Xun Chen, Kuang-Wu Pan, et al.
Cellular Signalling (2023) Vol. 112, pp. 110903-110903
Closed Access | Times Cited: 1
CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
Qiong Zou, Yuping Zhang, Daoqi Zhu, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
LncRNA Miat knockdown enhances pirarubicin‐mediated anticancer sensitivity in breast cancer cells
Peng Huang, Hongyuan Cheng, Jiahua Ji, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 1, pp. 23-30
Closed Access
Page 1

Scroll to top